deltatrials
Completed PHASE3 NCT00345787

Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Osteoarthritic Pain of the Hip or Knee

Sponsor: Mundipharma K.K.

Conditions Osteoarthritis Pain
Interventions Buprenorphine Transdermal System Placebo
Updated 6 times since 2017 Last updated: Apr 11, 2008 Started: May 31, 2006 Primary completion: Aug 31, 2007 Completion: Aug 31, 2007

A PHASE3 clinical study on Osteoarthritis and Pain, this trial is completed. The trial is conducted by Mundipharma K.K. and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mundipharma K.K.
Data source: Mundipharma Pte Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adachi City, Japan, Annaka, Japan, Arakawa City, Japan, Chitose, Japan, Edogawa City, Japan, Fukui-shi, Japan, Hikone, Japan, Himi, Japan, Ichikawa, Japan, Isahaya, Japan and 18 more location s